Compare ENTX & FNWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENTX | FNWB |
|---|---|---|
| Founded | 2010 | 1923 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.0M | 83.1M |
| IPO Year | 2018 | 2015 |
| Metric | ENTX | FNWB |
|---|---|---|
| Price | $1.62 | $9.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $10.00 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 208.2K | 40.8K |
| Earning Date | 11-14-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 1.51% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $124,000.00 | ★ $54,052,000.00 |
| Revenue This Year | N/A | $31.86 |
| Revenue Next Year | N/A | $10.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 25.25 | 6.47 |
| 52 Week Low | $1.50 | $6.05 |
| 52 Week High | $3.22 | $12.10 |
| Indicator | ENTX | FNWB |
|---|---|---|
| Relative Strength Index (RSI) | 33.35 | 44.58 |
| Support Level | $1.53 | $9.26 |
| Resistance Level | $1.99 | $9.48 |
| Average True Range (ATR) | 0.19 | 0.15 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 12.07 | 27.03 |
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.